AMSTERDAM, THE NETHERLANDS — Marcel Wubbolts has been named chief technology officer of Corbion, responsible for the company’s global R.&D. organization, effective Nov. 1. He will be part of Corbion’s Executive Committee.
Dr. Wubbolts currently is chief technology officer at DSM. During his 20 years of service at DSM he has held several science leadership positions in biochemistry and biotechnology, with a focus on developing sustainable production methods for intermediates for pharma, nutritional and materials applications. He is the chair of the Governing Board of the Biobased Industries Joint Undertaking, a public-private partnership between the E.U. and the Biobased Industries Consortium.
He received a doctorate degree in mathematics and natural sciences from the University of Groningen.
“Our commitment to innovation is deeply embedded in our strategy and culture; our global R.&D. team works every day on turning science into innovations that meet our customer needs,” said Tjerk de Ruiter, chief executive officer of Corbion. “We are very happy to welcome Marcel to Corbion, and we believe his extensive experience, passion and keen eye for scientifically relevant applications make him well suited to lead Corbion’s R.&D. organization and drive our innovation agenda to an even higher level.”
